GW-501516, also known as cardarine, is a synthetic agonist of the PPAR-δ (delta) receptors that presents benefits regarding primarily fat loss, lipid profile regulation, and cardiovascular endurance. Though it has few human clinical trials (which were conducted by GlaxoSmithKline), the data we do have available seems promising.
Mechanism of Action